|
WO1998006437A2
(en)
*
|
1996-08-13 |
1998-02-19 |
Chiron Corporation |
Compositions and methods for polynucleotide delivery
|
|
US6635623B1
(en)
*
|
1997-06-13 |
2003-10-21 |
Baylor College Of Medicine |
Lipoproteins as nucleic acid vectors
|
|
EP1002103B1
(en)
|
1997-08-04 |
2007-10-17 |
Cell Genesys, Inc. |
A human glandular kallikrein enhancer, vectors comprising the enhancer and methods of use thereof
|
|
US6197332B1
(en)
|
1997-08-13 |
2001-03-06 |
Chiron Corporation |
Lipid-conjugated polyamide compounds and related compositions and methods thereof
|
|
US5973119A
(en)
*
|
1998-06-05 |
1999-10-26 |
Amgen Inc. |
Cyclin E genes and proteins
|
|
US6344541B1
(en)
*
|
1998-09-25 |
2002-02-05 |
Amgen Inc. |
DKR polypeptides
|
|
US8624010B1
(en)
|
1999-02-03 |
2014-01-07 |
Steven K. Yoshinaga |
Nucleic acids encoding B7RP1
|
|
WO2000046240A2
(en)
*
|
1999-02-03 |
2000-08-10 |
Amgen Inc. |
Polypeptides involved in immune response
|
|
US7708993B2
(en)
*
|
1999-02-03 |
2010-05-04 |
Amgen Inc. |
Polypeptides involved in immune response
|
|
AU3770800A
(en)
|
1999-03-26 |
2000-10-16 |
Amgen, Inc. |
Beta secretase genes and polypeptides
|
|
US6281005B1
(en)
|
1999-05-14 |
2001-08-28 |
Copernicus Therapeutics, Inc. |
Automated nucleic acid compaction device
|
|
WO2001013723A1
(en)
*
|
1999-08-20 |
2001-03-01 |
Mirus Corporation |
Charge reversal of polyion complexes
|
|
US7408047B1
(en)
*
|
1999-09-07 |
2008-08-05 |
Amgen Inc. |
Fibroblast growth factor-like polypeptides
|
|
US7459540B1
(en)
*
|
1999-09-07 |
2008-12-02 |
Amgen Inc. |
Fibroblast growth factor-like polypeptides
|
|
US6900043B1
(en)
*
|
1999-09-21 |
2005-05-31 |
Amgen Inc. |
Phosphatases which activate map kinase pathways
|
|
US20050239061A1
(en)
*
|
2000-03-01 |
2005-10-27 |
Marshall William S |
Identification and use of effectors and allosteric molecules for the alteration of gene expression
|
|
US7514239B2
(en)
|
2000-03-28 |
2009-04-07 |
Amgen Inc. |
Nucleic acid molecules encoding beta-like glycoprotein hormone polypeptides and heterodimers thereof
|
|
MXPA02012718A
(es)
*
|
2000-06-28 |
2003-10-06 |
Amgen Inc |
Moleculas semejantes a b7 y sus usos.
|
|
MXPA02012747A
(es)
|
2000-06-28 |
2003-09-25 |
Amgen Inc |
Moleculas del receptor de linfopoietina estromica timica y sus usos.
|
|
AU2002217969B2
(en)
|
2000-11-28 |
2007-12-20 |
Amgen Canada Inc. |
Polypeptides involved in immune response
|
|
US6652886B2
(en)
|
2001-02-16 |
2003-11-25 |
Expression Genetics |
Biodegradable cationic copolymers of poly (alkylenimine) and poly (ethylene glycol) for the delivery of bioactive agents
|
|
WO2003072738A2
(en)
*
|
2002-02-22 |
2003-09-04 |
Board Of Trustees Of The University Of Illinois |
Beta chain-associated regulator of apoptosis
|
|
US7662924B2
(en)
*
|
2002-02-22 |
2010-02-16 |
The Board Of Trustees Of The University Of Illinois |
Beta chain-associated regulator of apoptosis
|
|
US20030186916A1
(en)
*
|
2002-03-12 |
2003-10-02 |
Lei Yu |
Vector for transfection of eukaryotic cells
|
|
GB0212826D0
(en)
*
|
2002-05-31 |
2002-07-10 |
Dna Res Innovations Ltd |
Materials and methods relating to polyions and substance delivery
|
|
MXPA05007019A
(es)
*
|
2002-12-30 |
2005-08-18 |
Amgen Inc |
Terapia de combinacion con factores co-estimuladores.
|
|
CA2564616C
(en)
*
|
2004-04-20 |
2016-08-30 |
Nastech Pharmaceutical Company Inc. |
Methods and compositions for enhancing delivery of double-stranded rna or a double-stranded hybrid nucleic acid to regulate gene expression in mammalian cells
|
|
US20060040882A1
(en)
*
|
2004-05-04 |
2006-02-23 |
Lishan Chen |
Compostions and methods for enhancing delivery of nucleic acids into cells and for modifying expression of target genes in cells
|
|
US20060035815A1
(en)
*
|
2004-05-04 |
2006-02-16 |
Nastech Pharmaceutical Company Inc. |
Pharmaceutical compositions for delivery of ribonucleic acid to a cell
|
|
JP4852539B2
(ja)
|
2004-06-22 |
2012-01-11 |
ザ・ボード・オブ・トラスティーズ・オブ・ザ・ユニバーシティ・オブ・イリノイ |
腫瘍細胞増殖をＦＯＸＭ１ｓｉＲＮＡによって阻害する方法
|
|
GB0513702D0
(en)
|
2005-07-04 |
2005-08-10 |
Sterix Ltd |
Compound
|
|
EP1934359A2
(en)
*
|
2005-09-08 |
2008-06-25 |
Nastech Pharmaceutical Company Inc. |
Pharmaceutical compositions for delivery of ribonucleic acid to a cell
|
|
EP1934360A2
(en)
*
|
2005-10-14 |
2008-06-25 |
Nastech Pharmaceutical Company Inc. |
Compounds and methods for peptide ribonucleic acid condensate particles for rna therapeutics
|
|
US20070281900A1
(en)
*
|
2006-05-05 |
2007-12-06 |
Nastech Pharmaceutical Company Inc. |
COMPOSITIONS AND METHODS FOR LIPID AND POLYPEPTIDE BASED siRNA INTRACELLULAR DELIVERY
|
|
US20070269892A1
(en)
*
|
2006-05-18 |
2007-11-22 |
Nastech Pharmaceutical Company Inc. |
FORMULATIONS FOR INTRACELLULAR DELIVERY dsRNA
|
|
US20070275923A1
(en)
*
|
2006-05-25 |
2007-11-29 |
Nastech Pharmaceutical Company Inc. |
CATIONIC PEPTIDES FOR siRNA INTRACELLULAR DELIVERY
|
|
US8282918B2
(en)
*
|
2007-07-30 |
2012-10-09 |
University Of Iowa Research Foundation |
Polynucleotides encoding RPA4/RPA32 hybrid polypeptides
|
|
US20100297242A1
(en)
*
|
2007-10-17 |
2010-11-25 |
Tae-Gwan Park |
Ldl-like cationic nanoparticles for deliverying nucleic acid gene, method for preparing thereof and method for deliverying nucleic acid gene using the same
|
|
EA024751B8
(ru)
|
2008-06-04 |
2020-01-31 |
Амген Инк. |
Мутанты fgf21 и их применение
|
|
EP2358749B1
(en)
|
2008-10-10 |
2018-07-18 |
Amgen, Inc |
Fgf21 mutants and uses thereof
|
|
US20120052069A1
(en)
|
2009-05-05 |
2012-03-01 |
Amgen Inc |
Fgf21 mutants and uses thereof
|
|
SMT202400036T1
(it)
|
2009-05-05 |
2024-03-13 |
Amgen Inc |
Mutanti fgf21 e loro utilizzi
|
|
AU2010262927A1
(en)
*
|
2009-06-17 |
2012-01-19 |
Amgen Inc. |
Chimeric FGF19 polypeptides and uses thereof
|
|
TWI373338B
(en)
*
|
2009-08-27 |
2012-10-01 |
Nat Univ Chung Cheng |
Pharmaceutical composition containing transcription factor decoys and their preparation method and applications
|
|
US20120225933A1
(en)
|
2009-11-05 |
2012-09-06 |
Gonzalez Aseguinolaza Gloria |
Regulated expression systems
|
|
MX2012006397A
(es)
*
|
2009-12-02 |
2012-11-30 |
Amgen Inc |
PROTEINAS DE ENLACE QUE ENLAZAN A FGFR1C HUMANO, ß-KLOTHO HUMANA Y TANTO FGFR1C HUMANO COMO ß-KLOTHO HUMANA.
|
|
UA109888C2
(uk)
|
2009-12-07 |
2015-10-26 |
|
ІЗОЛЬОВАНЕ АНТИТІЛО АБО ЙОГО ФРАГМЕНТ, ЩО ЗВ'ЯЗУЄТЬСЯ З β-КЛОТО, РЕЦЕПТОРАМИ FGF І ЇХНІМИ КОМПЛЕКСАМИ
|
|
US9517264B2
(en)
|
2010-04-15 |
2016-12-13 |
Amgen Inc. |
Human FGF receptor and β-Klotho binding proteins
|
|
AU2011255203B2
(en)
|
2010-05-21 |
2016-01-21 |
Peptimed, Inc. |
Reagents and methods for treating cancer
|
|
WO2012095548A2
(es)
|
2011-01-13 |
2012-07-19 |
Centro De Investigación Biomédica En Red De Enfermedades Neurodegenerativas (Ciberned) |
Compuestos para el tratamiento de enfermedades neurodegenerativas
|
|
US9644038B2
(en)
|
2011-12-21 |
2017-05-09 |
The Regents Of The University Of California |
Apolipoprotein nanodiscs with telodendrimer
|
|
US10005936B2
(en)
*
|
2012-11-23 |
2018-06-26 |
Nanyang Technological University |
Photoactive bioadhesive compositions
|
|
PH12022550138A1
(en)
|
2013-03-13 |
2023-03-06 |
Amgen Inc |
Proteins specific for baff and b7rp1 and uses thereof
|
|
US9458246B2
(en)
|
2013-03-13 |
2016-10-04 |
Amgen Inc. |
Proteins specific for BAFF and B7RP1
|
|
EP3079668A1
(en)
|
2013-12-09 |
2016-10-19 |
Durect Corporation |
Pharmaceutically active agent complexes, polymer complexes, and compositions and methods involving the same
|
|
WO2017035326A1
(en)
|
2015-08-25 |
2017-03-02 |
Lawrence Livermore National Security, Llc |
Stable nanolipoprotein particles and related compositions methods and systems
|
|
US10183058B2
(en)
|
2016-06-17 |
2019-01-22 |
Nymox Corporation |
Method of preventing or reducing the progression of prostate cancer
|
|
US10172910B2
(en)
|
2016-07-28 |
2019-01-08 |
Nymox Corporation |
Method of preventing or reducing the incidence of acute urinary retention
|
|
US10532081B2
(en)
|
2016-09-07 |
2020-01-14 |
Nymox Corporation |
Method of ameliorating or preventing the worsening or the progression of symptoms of BPH
|
|
WO2018204421A2
(en)
|
2017-05-02 |
2018-11-08 |
Lawrence Livermore National Security, Llc |
Momp telonanoparticles, and related compositions, methods and systems
|
|
US12083223B2
(en)
*
|
2017-05-02 |
2024-09-10 |
Lawrence Livermore National Security, Llc |
Nanolipoprotein particles and related compositions methods and systems for loading RNA
|
|
EP4534075A3
(en)
|
2019-10-28 |
2025-12-17 |
MedImmune Limited |
Dry powder formulations of thymic stromal lymphopoietin (tslp)-binding antibodies and methods of use thereof
|